Continuous Chest Compressions vs AHA Standard CPR of 30:2

NCT01372748 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 23711

Last updated 2016-12-28

Study results available
· View outcomes & findings →

Summary

The primary aim of the trial is to compare survival to hospital discharge after continuous chest compressions (CCC) versus standard American Heart Association (AHA) recommended cardiopulmonary resuscitation (CPR) with interrupted chest compressions (ICC) in patients with out-of-hospital cardiac arrest (OOHCA). The primary null hypothesis will be that the rate of survival to hospital discharge is not affected by use of continuous compressions with passive or positive pressure ventilation (intervention group) versus CPR with compressions interrupted for ventilation at a ratio of 30:2 (control group).

Conditions

  • Out of Hospital Cardiac Arrest

Interventions

OTHER

Standard CPR

30:2 CPR consists of 3 cycles of standard CPR with each cycle consisting of 30 chest compressions with a pause for 2 ventilations at a compression:ventilation ratio of 30:2. CCC consists of a series of three cycles of continuous chest compressions without pauses for ventilation. In either group, each cycle will be followed by rhythm analysis until three cycles are completed or restoration of spontaneous circulation (ROSC), whichever occurs first.

OTHER

Continuous chest compressions

Continuous chest compressions during the first 6 minutes of the resuscitation.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • Heart and Stroke Foundation of Canada

    collaborator OTHER
  • American Heart Association

    collaborator OTHER
  • Defence Research and Development Canada

    collaborator INDUSTRY
  • U.S. Army Medical Research and Development Command

    collaborator FED
  • University of Washington

    lead OTHER

Principal Investigators

  • Myron Weisfeldt, MD, MD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2015-08-31
Completion
2015-11-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01372748 on ClinicalTrials.gov